melitac 12.1
Vaccineexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT00977145)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Clostridium tetaniImmunity, active
Clostridium tetani immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- melitac 12.1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01585350 | Phase 1 | Oct 1, 2012 | National Cancer Institute (NCI), Oncovir, Inc., University of Virginia |
| NCT00977145 | Phase 1 | Nov 1, 2009 | University of Virginia |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Virginia | Academic/Hospital | 2 | 2 | 1 | 2009 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2012 |
| Oncovir, Inc. | For profit | 1 | 0 | 1 | 2012 |
3 organizations
Page 1 / 1